Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-07-03
1988-04-19
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544250, A61K 31505, C07D51304
Patent
active
047389648
ABSTRACT:
The novel compound, 5H-thiazolo[2,3-b]quinazolin-3(2H)-one, and derivatives thereof in which a nuclear hydrogen of its benzene ring is replaced by lower alkyl, alkoxy, halogen, trifluoromethyl, NO.sub.2 or NH.sub.2 ; useful as anti-hypertensive agents and immunosuppressive agents.
REFERENCES:
patent: 2527266 (1950-10-01), Kendall et al.
patent: 4083980 (1978-04-01), Schromm et al.
patent: 4282360 (1981-08-01), LeMahieu
patent: 4486221 (1984-12-01), Seybold et al.
patent: 4588812 (1986-05-01), Saeva et al.
Lui et al., Arch Pharm., 316, pp. 569-571 (06/83).
Lui et al., Chemical Abstracts, vol. 99, 88155g (1983) (abstract of Lui et al., Arch. Pharm. 316, No. 6, pp. 569-571).
Grosso et al., J. Med. Chem., vol. 23, No. 11, pp. 1261-1264 (1980).
Georgiev Vassil S.
Saeva Grace A.
Daus Donald G.
Pennwalt Corporation
Rivers Diana G.
LandOfFree
Method of suppressing the immune system comprising administering does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of suppressing the immune system comprising administering, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of suppressing the immune system comprising administering will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2175370